Acute lung injury in 2005: A mini-review

Journal of Organ Dysfunction

Volumn 2, Issue 1, 2006, Pages 15-19

  Spragg, Roger ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Pulmonary surfactant; Sepsis

Indexed keywords

2 OXO 4 THIAZOLIDINECARBOXYLIC ACID; ACETYLCYSTEINE; ACICLOVIR; CORTICOSTEROID; DAZOXIBEN; DROTRECOGIN; ETANERCEPT; GLUCOCORTICOID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDOMETACIN; INTERLEUKIN 10; KETOCONAZOLE; LEUKOCYTE ELASTASE INHIBITOR; LISOFYLLINE; LUCINACTANT; LUSUPULTIDE; NITRIC OXIDE; PENTOXIFYLLINE; PROSTAGLANDIN E1; SURFACTANT; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; EXTRACORPOREAL OXYGENATION; GLUCOSE BLOOD LEVEL; HIGH FREQUENCY VENTILATION; HUMAN; INCIDENCE; LUNG EDEMA; MORTALITY; PATIENT POSITIONING; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 33745061305     PISSN: 17471060     EISSN: 17471079     Source Type: Journal    
DOI: 10.1080/17471060600580714     Document Type: Review

References (22)

1. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24.
2. Artigas A, Bernard GR, Carlet J, Dreyfuss D, Gattinoni L, Hudson L, et al. The American-European Consensus Conference on ARDS. Part 2: ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome. Am J Respir Crit Care Med 1998;157:1332-47.
3. Takeda S, Ishizaka A, Fujino Y, Fukuoka T, Nagano O, Yamada Y, et al. Time to change diagnostic criteria of ARDS: towards the disease entity-based subgrouping. Pulm Pharmacol Ther 2005;18:115-9.
4. Ferguson ND, Kacmarek RM, Chiche JD, Singh JM, Hallett DC, Mehta S, et al. Screening of ARDS patients using standardized ventilator settings: influence on enrollment in a clinical trial. Intensive Care Med 2004;30:1111-6.
5. Goss CH, Brower RG, Hudson LD, Rubenfeld GD. Incidence of acute lung injury in the United States. Crit Care Med 2003;31:1607-11.
6. Bersten AD, Edibam C, Hunt T, Moran J. Incidence and mortality of acute lung injury and the acute respiratory distress syndrome in three Australian States. Am J Respir Crit Care Med 2002;165:443-8.
7. Hughes M, Grant IS, MacKirdy FN. Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. Am J Respir Crit Care Med 162:332-3.
8. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-8.
9. Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004;351:327-36.
10. Lewandowski K, Metz J, Deutschmann C, Preiss H, Kuhlen R, Artigas A, et al. Incidence, severity, and mortality of acute respiratory failure in Berlin, Germany. Am J Respir Crit Care Med 1995;151:1121-5.
11. Luhr OR, Antonsen K, Karlsson M, Aardal S, Thorsteinsson A, Frostell CG, et al. Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. The ARF Study Group. Am J Respir Crit Care Med 1999;159:1849-61.
12. Doyle RL, Szaflarski N, Modin GW, Wiener-Kronish JP, Matthay MA. Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med 1993;152:1818-24.
13. Lu Y, Song Z, Zhou X, Huang S, Zhu D, Yang CB, et al. A 12-month clinical survey of incidence and outcome of acute respiratory distress syndrome in Shanghai intensive care units. Intensive Care Med 2004;30:2197-203.
14. Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002;30:119-41.
15. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 2003;31:359-66.
16. Drakulovic MB, Torres A, Bauer TT, Nicolas JM, Nogue S, Ferrer M. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 1999;354:1851-8.
17. Annane D, Bellissant E. Prognostic value of cortisol response in septic shock. J Am Med Assoc 2000;284:308-9.
18. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. J Am Med Assoc 2002;288:862-71.
19. Adhikari N, Burns KE, Meade MO. Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev 2005;CD004477
20. Spragg RG, Lewis JF, Walmrath H-D, Johannigman J, Bellingan G, Laterre PF, et al. Effect of recombinant surfactant protein-C based surfactant on the acute respiratory distress syndrome. N Engl J Med 2004;351:884-92.
21. Schoenfeld DA, Bernard GR. Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med 2002;30:1772-7.
22. Spragg RG, Lewis JF. Surfactant therapy in the acute respiratory distress syndrome. In: Matthay MA, editor. Acute respiratory distress syndrome. New York: Marcel Dekker; 2003; p. 533-62.